全球经导管器械市场规模、份额、成长分析、按产品（经导管栓塞和闭塞器械、经导管替代器材）、按应用（心血管、肿瘤）- 2024-2031 年产业预测

Global Transcatheter Devices Market Size, Share, Growth Analysis, By Product(Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices), By Application(Cardiovascular, Oncology) - Industry Forecast 2024-2031

出版日期: 2024年03月04日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球经导管器材市场规模为123.2亿美元，预计将从2023年的139.9亿美元成长到2031年的386.6亿美元，预测期间（2024-2031年）复合CAGR为13.55%。

全球经导管设备市场在医疗保健领域呈现有趣的变化。这些设备变得越来越受欢迎，因为它们提供了一种用更小的切口进行手术的方法，这意味着患者的不适感更少，恢復更快。它们可用于治疗各种健康问题，例如心臟问题，而无需进行传统的开放性手术。该市场正在成长，因为越来越多的人变老并患有慢性病，医疗技术越来越好。人们，包括医生和患者，都希望得到能够帮助他们更快康復并减少术后问题的治疗方法，而经导管设备正好符合这项要求。然而，市场的成长也面临着挑战，例如有关使用设备的规则、使用它们获得报酬以及需要特殊培训才能正确使用它们。儘管如此，关于如何改进这些设备的持续研究和新想法，以及医生和设备製造商之间的合作，将塑造经导管设备全球市场的未来。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

CryoLife, Inc. (US)
Edwards Lifesciences Corporation (US)
Abbott (US)
Boston Scientific Corporation (US)
enaValve Technology, Inc. (US)
Terumo Corporation (Japan)
Neovasc Inc. (Canada)
Meril Life Sciences Pvt. Ltd. (India)
Symetis SA (Switzerland)
Venus Medtech (Hangzhou) Inc. (China)
Medtronic plc (Ireland)
WL Gore & Associates (US)
JenaValve Technology, Inc. (US)
Xeltis AG (Switzerland)
LivaNova PLC (UK)
Endologix Inc. (US)
B. Braun Melsungen AG (Germany)
Biosensors International Group, Ltd. (Singapore)
Direct Flow Medical, Inc. (US)
Transcatheter Technologies GmbH (Germany)

简介目录

Product Code: SQMIG35A2584

Global Transcatheter Devices Market size was valued at USD 12.32 billion in 2022 and is poised to grow from USD 13.99 billion in 2023 to USD 38.66 billion by 2031, growing at a CAGR of 13.55% in the forecast period (2024- 2031).

The global market for transcatheter devices is showing interesting changes in the healthcare field. These devices are becoming more popular because they offer a way to perform surgeries with smaller incisions, which means less discomfort and faster recovery for patients. They're used for various health issues, like heart problems, without needing to do traditional open surgeries. The market is growing because more people are getting older and having chronic illnesses, and medical technology is getting better. People, including doctors and patients, want treatments that help them recover faster and have fewer problems afterward, and transcatheter devices fit the bill. However, there are challenges to the market's growth, like rules about using the devices, getting paid for using them, and needing special training to use them properly. Still, ongoing research and new ideas about how to make these devices better, along with cooperation between doctors and device makers, will shape the future of the global market for transcatheter devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Devices Market Segmental Analysis

The global Transcatheter Devices Market is segmented on the basis of Application, Product, and Region. By Application, the market is segmented into Cardiovascular, Oncology, Neurology, Urology, and Others. By Product, the market is segmented into Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices, Transcatheter Repair Devices. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Transcatheter Devices Market

As medical technology advances, there's a bigger focus on procedures that make patients less uncomfortable, shorten hospital stays, and speed up recovery times. Transcatheter devices, like stents, valves, and embolization devices, are vital for performing less invasive procedures in different medical fields. These devices let doctors reach specific areas in the body through small cuts, meaning they don't need to do traditional open surgeries. Because patients want procedures that help them recover faster with fewer problems, the use of transcatheter devices is increasing. This trend is pushing innovation and changing how treatments are done in healthcare.

Restraints in the Global Transcatheter Devices Market

Creating and selling these new medical devices usually involves a lot of clinical trials and getting approval from regulators. Transcatheter procedures are complicated, and using new technology can have risks, so it's important to carefully check them to keep patients safe. Dealing with different rules in different places can slow down getting products out and make it more expensive for companies. Because of this, these rules can slow down how quickly new devices are made and get into the market, which is a big restraint for the global market for transcatheter devices.

Market Trends of the Global Transcatheter Devices Market

TAVR (Transcatheter Aortic Valve Replacement) has become increasingly popular as a less invasive option compared to traditional open-heart surgery for treating aortic valve diseases, especially in older patients and those at high risk during surgery. This trend is driven by the procedure's benefits of faster recovery, shorter hospital stays, and fewer complications, which align with patients' preferences for less invasive treatments. With the growing number of elderly patients and advancements in TAVR techniques, its use is expanding across different regions. Additionally, ongoing research and development are improving TAVR technologies, making them more widely applicable and ensuring better patient outcomes in the global transcatheter devices market.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Transcatheter Devices Market by Product

Market Overview
Transcatheter Embolization and Occlusion Devices
Transcatheter Replacement Devices
and Transcatheter Repair Devices

Global Transcatheter Devices Market by Application

Market Overview
Cardiovascular
Oncology
Neurology
Urology
and Others

Global Transcatheter Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

CryoLife, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
enaValve Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neovasc Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Symetis SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Venus Medtech (Hangzhou) Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W.L. Gore & Associates (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JenaValve Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xeltis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International Group, Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Direct Flow Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transcatheter Technologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments